HIV-2 diagnosis and quantification in high-risk patients

Philip A. Chan, Sarah E. Wakeman, Timothy Flanigan, Susan Cu-Uvin, Erna Kojic, Rami Kantor

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

Current diagnostic assays for HIV-1 do not always test for the presence of HIV-2 in the United States. We present the case of a patient from Cape Verde, who was admitted to our hospital with rapidly deteriorating neurological function and multiple white matter lesions on MRI likely secondary to progressive multifocal leukoencephalopathy (PML). Initially, the patient had a positive EIA for HIV, but a negative HIV-1 Western Blot and no viral load detected on a branched-DNA assay. A repeat viral load by reverse transcriptase methodology (RT-DNA) detected 121,000 copies and an HIV-2 Western Blot was positive. The case highlights an extremely rare presentation of HIV-2 with severe neurological disease. We discuss the different tests available for the diagnosis and monitoring of HIV-2 in the United States.

Original languageEnglish
Article number18
JournalAIDS Research and Therapy
Volume5
DOIs
StatePublished - 14 Aug 2008
Externally publishedYes

Fingerprint

Dive into the research topics of 'HIV-2 diagnosis and quantification in high-risk patients'. Together they form a unique fingerprint.

Cite this